Yuwa Ando

414 total citations
5 papers, 68 citations indexed

About

Yuwa Ando is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Yuwa Ando has authored 5 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hepatology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Yuwa Ando's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Genetic factors in colorectal cancer (2 papers). Yuwa Ando is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Genetic factors in colorectal cancer (2 papers). Yuwa Ando collaborates with scholars based in Japan. Yuwa Ando's co-authors include Masataka Tsuge, Tomokazu Kawaoka, Michio Imamura, Eisuke Murakami, Shinsuke Uchikawa, Takashi Nakahara, Atsushi Ono, Hiroshi Aikata, Yumi Kosaka and Kazuaki Chayama and has published in prestigious journals such as Journal of Gastroenterology and Hepatology, Oncology and European Journal of Gastroenterology & Hepatology.

In The Last Decade

Yuwa Ando

5 papers receiving 67 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuwa Ando Japan 5 48 38 20 16 14 5 68
Yumi Kosaka Japan 5 52 1.1× 52 1.4× 20 1.0× 19 1.2× 14 1.0× 5 83
Antonella Cammarota Italy 6 40 0.8× 36 0.9× 22 1.1× 23 1.4× 12 0.9× 18 77
Peter R. Galle Germany 5 63 1.3× 24 0.6× 14 0.7× 16 1.0× 24 1.7× 18 114
Keisuke Koroki Japan 5 58 1.2× 20 0.5× 15 0.8× 27 1.7× 15 1.1× 17 89
Yehia I. Abugabal United States 3 46 1.0× 24 0.6× 6 0.3× 13 0.8× 12 0.9× 12 80
Yamil Alonso Lopez Chuken Mexico 3 84 1.8× 32 0.8× 29 1.4× 21 1.3× 11 0.8× 6 103
Jigjidsuren Chinburen Mongolia 5 51 1.1× 17 0.4× 10 0.5× 27 1.7× 24 1.7× 9 108
Kirsty Lloyd United Kingdom 5 12 0.3× 24 0.6× 23 1.1× 7 0.4× 14 1.0× 9 82
Yoko Yoshimaru Japan 6 41 0.9× 16 0.4× 14 0.7× 11 0.7× 6 0.4× 16 61

Countries citing papers authored by Yuwa Ando

Since Specialization
Citations

This map shows the geographic impact of Yuwa Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuwa Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuwa Ando more than expected).

Fields of papers citing papers by Yuwa Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuwa Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuwa Ando. The network helps show where Yuwa Ando may publish in the future.

Co-authorship network of co-authors of Yuwa Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Yuwa Ando. A scholar is included among the top collaborators of Yuwa Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuwa Ando. Yuwa Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Nakahara, Takashi, Yuwa Ando, Yasutoshi Fujii, et al.. (2023). Sodium-glucose cotransporter-2 inhibitors improve FibroScan-aspartate aminotransferase scores in patients with nonalcoholic fatty liver disease complicated by type 2 diabetes. European Journal of Gastroenterology & Hepatology. 35(9). 989–996. 6 indexed citations
2.
Uchikawa, Shinsuke, Tomokazu Kawaoka, Yuwa Ando, et al.. (2020). Trends in Hepatic Functional Reserve of Patients with Hepatocellular Carcinoma Treated with Tyrosine Kinase Inhibitors. Oncology. 98(10). 727–733. 7 indexed citations
3.
Ando, Yuwa, Masami Yamauchi, Yumi Kosaka, et al.. (2020). Complete response to pembrolizumab in advanced hepatocellular carcinoma with microsatellite instability. Clinical Journal of Gastroenterology. 13(5). 867–872. 16 indexed citations
4.
Kawaoka, Tomokazu, Yuwa Ando, Masami Yamauchi, et al.. (2020). Incidence of microsatellite instability‐high hepatocellular carcinoma among Japanese patients and response to pembrolizumab. Hepatology Research. 50(7). 885–888. 34 indexed citations
5.
Kodama, Kenichiro, Akira Hiramatsu, Yuwa Ando, et al.. (2020). Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 36(6). 1685–1693. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026